Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

Clinical trial NCT02152943 · COMPLETED

Trial details

NCT number: NCT02152943
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm Estrogen Receptor Positive HER2/Neu Positive Postmenopausal Premenopausal Progesterone Receptor Positive Recurrent Breast Carcinoma Refractory Breast Carcinoma Refractory Hormone Receptor Positive Breast Carcinoma Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7

Start date: 2014-07-17
Primary completion: 2020-12-14
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.